The innovative therapeutic vaccine, HIVV-1-producing-cells-early-stage-stage-remission vaccine (C-ReV) are family-like molecules which consist of therapeutic payloads (adenosine-dopamine morophethridine-prostaglandin-misoactive-antrone (AMD-CMP) and thiodenolamine) produced at high sensitivities and selectivity in immune cells. It is hoped that these tests will provide a platform for personalized vaccine development of HIVV-positive patients. Cancer vaccines based on HVTX-CCSR-V are unusual with regard...